Tag: kidney transplantation

Fresenius Medical Care North America announces three key clinical leadership appointments

Fresenius Medical Care North America (FMCNA) has announced three key clinical leadership appointments to help drive priorities, including improving patient outcomes, adopting connected health technologies...
kidney project ibak

Bioartificial kidney device receives KidneyX award after progressing to preclinical model

An implantable bioartificial kidney device (iBAK)—which promises to free kidney disease patients from dialysis machines and transplant waiting lists—has taken another step towards becoming...

Natera launches Prospera with quantification to improve kidney graft rejection testing

Natera has announced the launch of Prospera with quantification, the only cell-free DNA (cfDNA) test for kidney rejection that provides three values—the quantity of...

ESOT 2021: Asian donor and Black recipient kidney grafts associated with...

Black transplant recipients and patients who received kidneys from Asian donors had a significantly higher risk of their kidney grafts failing within seven years,...
kidney transplantation covid-19

ESOT 2021: Kidney transplants plummeted by 40% during first wave of...

The number of solid organ transplants performed during the first wave of the COVID-19 pandemic in 2020 plunged by nearly a third (31%) compared...
evergreen nephrology

Rubicon Founders launches Evergreen Nephrology with intent to “transform” kidney care

Rubicon Founders has announced the launch of Evergreen Nephrology—a company partnering with nephrologists to transform kidney care, according to a press release. Evergreen is...

Pilot study of third COVID-19 vaccine dose in kidney transplant recipients...

A pilot study has begun to assess the antibody response to a third dose of an authorised COVID-19 mRNA vaccine in kidney transplant recipients...
NKF transplant recommendations

NKF publishes recommendations to move thousands of patients from dialysis to...

The National Kidney Foundation (NKF) has released a position paper, developed by 16 nephrology experts from 13 institutions, with recommendations designed to navigate future research...
kidney graft survival rates

Hansa Biopharma announces three-year graft survival of 84% after imlifidase treatment...

Hansa Biopharma has announced three-year follow-up data on graft survival rates in crossmatch positive patients who received imlifidase prior to kidney transplantation. As reported...
kidney transplant referrals

Higher kidney transplant referral rates found in non-profit dialysis facilities versus...

New research indicates that patients with kidney failure who receive care at for-profit dialysis facilities are less likely to be referred for kidney transplants...
geko device

Novel device reduces swelling and surgical site infection after kidney transplantation

Researchers from the Lawson Health Research Institute at London Health Sciences Centre (LHSC) in London, Canada have reported that a simple medical device reduced...